Drug intelligence / Profile preview

AniLavo Rinsing Liquid

Development stage: Unknown
Lead developer: Repolar Pharmaceuticals
Administration: Topical

Overview

AniLavo Rinsing Liquid is a veterinary medical device developed by Repolar Pharmaceuticals for professional use in animals. It is a topical resin-based rinsing solution formulated using proprietary Resol Technology, which extracts active components from Norway spruce (*Picea abies*) resin. The product is specifically indicated for the cleansing and rinsing of anal glands, wounds, wound cavities, and opened abscesses. AniLavo exhibits broad-spectrum antimicrobial activity, including efficacy against resistant strains like MRSA and VRE, and possesses biofilm-eradicating properties. It also provides a calming effect to reduce skin irritation and forms a protective layer on the treated area that does not require rinsing off.

Brand names: AniLavo
Other names: AniLavo Rinsing Liquid

Beyond the preview

Go deeper on AniLavo Rinsing Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AniLavo Rinsing Liquid.

Explore the full profile